Managed Account Advisors’s AbbVie ABBV Stock Holding History

Managed Account Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$567M	Buy	8,445,423 +2,024,516	+32%	+$132M	0.47%	44
2015 Q1	$376M	Sell	6,420,907 -36,942	-0.6%	-$2.23M	0.33%	79
2014 Q4	$423M	Buy	6,457,849 +224,818	+4%	+$14.2M	0.42%	48
2014 Q3	$360M	Buy	6,233,031 +1,114,919	+22%	+$61.9M	0.4%	49
2014 Q2	$289M	Buy	5,118,112 +924,956	+22%	+$48.5M	0.35%	62
2014 Q1	$216M	Sell	4,193,156 -257,208	-6%	-$13M	0.28%	87
2013 Q4	$235M	Buy	4,450,364 +444,906	+11%	+$21.9M	0.32%	68
2013 Q3	$179M	Buy	4,005,458 +91,794	+2%	+$4.07M	0.26%	88
2013 Q2	$162M	Buy	+3,913,664	New	+$171M	0.25%	97

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Managed Account Advisors's ABBV Position: Q2 2015 in Review

Managed Account Advisors increased its AbbVie (ABBV) stake by 32% in Q2 2015, buying an estimated $132M and bringing the position to 8,445,423 shares worth $567M. The position accounts for 0.47% of the portfolio, ranked #44.

Managed Account Advisors first reported a position in ABBV in Q2 2013 and has held it in 9 quarters since. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Managed Account Advisors held 8,445,423 shares of AbbVie worth $567M as of Q2 2015.
Managed Account Advisors bought 2,024,516 AbbVie shares in Q2 2015, an estimated $132M.
AbbVie made up 0.47% of Managed Account Advisors's portfolio in Q2 2015, its #44 holding.
Managed Account Advisors first reported a position in AbbVie in Q2 2013 and has held it in 9 quarters since.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.